Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients [NA]

View source ↗

Summary

This document describes a clinical study protocol evaluating alpha-radiation therapy for cutaneous squamous cell carcinoma in immunocompromised patients. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Squamous Cell Carcinoma, Alpha Radiation | NA | Status: NOT_YET_RECRUITING